ABAXIS Company Profile (NASDAQ:ABAX)


ABAXIS logoAbaxis, Inc. is a developer, manufacturer and marketer of portable blood analysis systems that are used in medical specialties in human or veterinary patient care to provide clinicians with blood constituent measurements. The Company markets and sells its products around the world through independent distributors and direct sales force. The Company's segments are the medical market and the veterinary market. The Company's medical market products include Piccolo chemistry analyzers and consumable products. The Company develops, manufactures and sells the Piccolo Xpress chemistry analyzer for use in human patient care to provide clinicians with blood constituent measurements. The Company's veterinary market product offerings include VetScan chemistry analyzers and veterinary reagent discs, VetScan hematology instruments and related reagent kits, VetScan VSpro specialty analyzers and related consumables, VetScan i-STAT analyzers and related consumables and VetScan rapid tests.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ABAX
  • CUSIP: 00256710
  • Web: www.abaxis.com
  • Market Cap: $1.04 billion
  • Outstanding Shares: 22,690,000
Average Prices:
  • 50 Day Moving Avg: $45.32
  • 200 Day Moving Avg: $48.19
  • 52 Week Range: $43.66 - $55.95
  • Trailing P/E Ratio: 32.30
  • Foreward P/E Ratio: 33.63
  • P/E Growth: 7.73
Sales & Book Value:
  • Annual Revenue: $227.78 million
  • Price / Sales: 4.56
  • Book Value: $11.97 per share
  • Price / Book: 3.82
  • Annual Dividend: $0.56
  • Dividend Yield: 1.2%
  • EBITDA: $49.81 million
  • Net Margins: 14.12%
  • Return on Equity: 10.85%
  • Return on Assets: 9.44%
  • Current Ratio: 5.67%
  • Quick Ratio: 4.65%
  • Average Volume: 111,928 shs.
  • Beta: 0.82
  • Short Ratio: 18.88

Frequently Asked Questions for ABAXIS (NASDAQ:ABAX)

What is ABAXIS's stock symbol?

ABAXIS trades on the NASDAQ under the ticker symbol "ABAX."

How often does ABAXIS pay dividends? What is the dividend yield for ABAXIS?

ABAXIS announced a quarterly dividend on Thursday, July 27th. Stockholders of record on Friday, September 1st will be given a dividend of $0.14 per share on Friday, September 15th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date is Wednesday, August 30th. View ABAXIS's Dividend History.

How were ABAXIS's earnings last quarter?

ABAXIS, Inc. (NASDAQ:ABAX) announced its quarterly earnings data on Thursday, July, 27th. The company reported $0.28 EPS for the quarter, missing analysts' consensus estimates of $0.33 by $0.05. The firm had revenue of $58.26 million for the quarter, compared to analyst estimates of $60.37 million. ABAXIS had a net margin of 14.12% and a return on equity of 10.85%. ABAXIS's revenue for the quarter was up 1.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.30 EPS. View ABAXIS's Earnings History.

When will ABAXIS make its next earnings announcement?

ABAXIS is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for ABAXIS.

Where is ABAXIS's stock going? Where will ABAXIS's stock price be in 2017?

6 equities research analysts have issued 1 year target prices for ABAXIS's shares. Their predictions range from $42.00 to $56.50. On average, they anticipate ABAXIS's share price to reach $48.63 in the next twelve months. View Analyst Ratings for ABAXIS.

Who are some of ABAXIS's key competitors?

Who are ABAXIS's key executives?

ABAXIS's management team includes the folowing people:

  • Clinton H. Severson, Chairman of the Board, Chief Executive Officer
  • Donald Peter Wood, President, Chief Operating Officer
  • Ross Taylor, Chief Financial Officer, Vice President - Finance, Secretary
  • Kenneth P. Aron Ph.D., Chief Technology Officer
  • Craig M. Tockman, Vice President - Animal Health Sales and Marketing for North America
  • Achim Henkel, Managing Director of Abaxis Europe GmbH
  • Vernon Edward Altman, Lead Independent Director
  • Richard J. Bastiani Ph.D., Independent Director
  • Michael D. Casey, Independent Director
  • Henk J. Evenhuis, Independent Director

How do I buy ABAXIS stock?

Shares of ABAXIS can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ABAXIS's stock price today?

One share of ABAXIS stock can currently be purchased for approximately $45.73.

MarketBeat Community Rating for ABAXIS (NASDAQ ABAX)
Community Ranking:  1.6 out of 5 (star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  237 (Vote Underperform)
Total Votes:  351
MarketBeat's community ratings are surveys of what our community members think about ABAXIS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ABAXIS (NASDAQ:ABAX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 4 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $48.63 (6.33% upside)
Consensus Price Target History for ABAXIS (NASDAQ:ABAX)
Price Target History for ABAXIS (NASDAQ:ABAX)
Analysts' Ratings History for ABAXIS (NASDAQ:ABAX)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
8/23/2017Bank of America CorporationReiterated RatingUnderperform -> Underperform$42.00HighView Rating Details
7/14/2017Stifel NicolausReiterated RatingHold$48.00LowView Rating Details
6/9/2017AegisInitiated CoverageHold$56.50HighView Rating Details
2/14/2017Canaccord GenuityReiterated RatingHold$48.00N/AView Rating Details
2/1/2017Seaport Global SecuritiesUpgradeBuyN/AView Rating Details
11/30/2016Northcoast ResearchDowngradeBuy -> NeutralN/AView Rating Details
8/16/2016Credit Suisse GroupReiterated RatingSell$39.00N/AView Rating Details
7/22/2016Feltl & Co.DowngradeHold -> SellN/AView Rating Details
4/1/2016CL KingInitiated CoverageNeutralN/AView Rating Details
1/29/2016Piper Jaffray CompaniesLower Price TargetNeutral$49.00 -> $45.00N/AView Rating Details
(Data available from 10/17/2015 forward)


Earnings History for ABAXIS (NASDAQ:ABAX)
Earnings by Quarter for ABAXIS (NASDAQ:ABAX)
Earnings History by Quarter for ABAXIS (NASDAQ ABAX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/23/2017$0.30N/AView Earnings Details
7/27/2017Q1 2018$0.33$0.28$60.37 million$58.26 millionViewN/AView Earnings Details
4/27/2017Q4 2017$0.33$0.33$58.04 million$58.20 millionViewN/AView Earnings Details
1/26/2017Q317$0.31$0.30$54.36 million$52.80 millionViewN/AView Earnings Details
10/25/2016Q217$0.35$0.34$60.69 million$58.60 millionViewListenView Earnings Details
7/21/2016Q117$0.32$0.30$58.70 million$57.70 millionViewListenView Earnings Details
4/28/2016Q416$0.32$0.36$56.62 million$57.00 millionViewListenView Earnings Details
1/28/2016Q316$0.33$0.35$58.52 million$52.90 millionViewListenView Earnings Details
10/27/2015Q216$0.32$0.34$56.20 million$56.00 millionViewListenView Earnings Details
7/23/2015Q116$0.28$0.31$53.75 million$53.10 millionViewListenView Earnings Details
4/30/2015Q415$0.27$0.17$55.62 million$52.00 millionViewN/AView Earnings Details
1/29/2015Q315$0.25$0.26$51.70 million$59.50 millionViewN/AView Earnings Details
10/21/2014Q215$0.23$0.24$50.55 million$53.90 millionViewListenView Earnings Details
7/24/2014Q115$0.19$0.21$46.95 million$47.50 millionViewN/AView Earnings Details
4/24/2014Q414$0.19$0.17$45.74 million$42.04 millionViewN/AView Earnings Details
1/31/2014Q314$0.20$0.14$49.47 million$40.00 millionViewN/AView Earnings Details
10/22/2013Q114$0.21$0.18$48.60 million$45.90 millionViewN/AView Earnings Details
7/25/2013Q1 2014$0.23$0.14$49.13 million$43.20 millionViewListenView Earnings Details
4/25/2013Q4 2013$0.26$0.30$52.47 million$50.00 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.20$0.22$45.75 million$49.80 millionViewListenView Earnings Details
10/23/2012$0.18$0.18ViewN/AView Earnings Details
7/26/2012$0.17$0.13ViewN/AView Earnings Details
4/26/2012$0.16$0.21ViewN/AView Earnings Details
1/26/2012$0.16$0.13ViewN/AView Earnings Details
10/25/2011$0.14$0.15ViewN/AView Earnings Details
7/28/2011$0.16$0.10ViewN/AView Earnings Details
4/28/2011$0.16$0.15ViewN/AView Earnings Details
1/27/2011$0.18$0.17ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for ABAXIS (NASDAQ:ABAX)
2017 EPS Consensus Estimate: $1.29
2018 EPS Consensus Estimate: $1.39
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.34$0.34$0.34
Q2 20171$0.34$0.34$0.34
Q3 20172$0.29$0.32$0.31
Q4 20172$0.27$0.33$0.30
Q1 20181$0.33$0.33$0.33
Q2 20181$0.38$0.38$0.38
Q3 20181$0.31$0.31$0.31
Q4 20181$0.37$0.37$0.37
(Data provided by Zacks Investment Research)


Current Dividend Information for ABAXIS (NASDAQ:ABAX)
Most Recent Dividend:9/15/2017
Annual Dividend:$0.56
Dividend Yield:1.22%
Payout Ratio:39.72% (Trailing 12 Months of Earnings)
49.56% (Based on This Year's Estimates)
41.18% (Based on Next Year's Estimates)
Dividend Payments by Quarter for ABAXIS (NASDAQ:ABAX)

Dividend History by Quarter for ABAXIS (NASDAQ ABAX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for ABAXIS (NASDAQ:ABAX)
Insider Ownership Percentage: 4.30%
Institutional Ownership Percentage: 97.27%
Insider Trades by Quarter for ABAXIS (NASDAQ:ABAX)
Institutional Ownership by Quarter for ABAXIS (NASDAQ:ABAX)
Insider Trades by Quarter for ABAXIS (NASDAQ:ABAX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/26/2017Achim HenkelInsiderSell650$48.87$31,765.50View SEC Filing  
5/8/2017Achim HenkelDirectorSell8,650$47.75$413,037.50View SEC Filing  
2/2/2017Richard BastianiDirectorSell4,000$51.12$204,480.00View SEC Filing  
12/6/2016Clinton SeversonCEOSell15,000$51.35$770,250.00View SEC Filing  
12/2/2016Kenneth AronInsiderSell5,000$51.09$255,450.00View SEC Filing  
9/9/2016Clinton SeversonCEOSell2,000$48.29$96,580.00View SEC Filing  
9/8/2016Prithipal SinghDirectorSell1,000$49.50$49,500.00View SEC Filing  
8/25/2016Prithipal SinghDirectorSell1,500$50.30$75,450.00View SEC Filing  
8/24/2016Donald Peter WoodInsiderSell8,500$50.21$426,785.00View SEC Filing  
6/9/2016Richard BastianiDirectorSell5,000$46.75$233,750.00View SEC Filing  
5/17/2016Achim HenkelDirectorSell5,000$44.43$222,150.00View SEC Filing  
5/9/2016Henk EvenhuisDirectorSell3,000$45.00$135,000.00View SEC Filing  
2/9/2016Vernon E AltmanDirectorBuy303$39.87$12,080.61View SEC Filing  
12/8/2015Craig TockmanVPSell560$54.44$30,486.40View SEC Filing  
2/9/2015Prithipal SinghDirectorSell2,500$60.50$151,250.00View SEC Filing  
12/8/2014Kenneth AronCTOSell2,000$56.68$113,360.00View SEC Filing  
11/25/2014Clinton SeversonCEOSell2,286$56.00$128,016.00View SEC Filing  
11/13/2014Clinton SeversonCEOSell10,000$55.00$550,000.00View SEC Filing  
11/5/2014Clinton SeversonCEOSell10,000$54.00$540,000.00View SEC Filing  
11/3/2014Alberto Santa InesCFOSell1,652$53.09$87,704.68View SEC Filing  
11/3/2014Clinton SeversonCEOSell5,000$53.00$265,000.00View SEC Filing  
10/31/2014Clinton SeversonCEOSell10,000$51.50$515,000.00View SEC Filing  
8/12/2014Richard BastianiDirectorSell1,000$45.40$45,400.00View SEC Filing  
7/30/2014Alberto Santa InesCFOSell10,738$47.81$513,383.78View SEC Filing  
7/29/2014Alberto Santa InesCFOSell17,293$48.01$830,236.93View SEC Filing  
6/5/2014Richard BastianiDirectorSell2,000$42.10$84,200.00View SEC Filing  
6/3/2014Richard BastianiDirectorSell4,000$41.88$167,520.00View SEC Filing  
5/22/2014Achim HenkelDirectorSell8,500$41.63$353,855.00View SEC Filing  
5/14/2014Henk EvenhuisDirectorSell4,000$44.06$176,240.00View SEC Filing  
5/1/2014Henk EvenhuisDirectorSell4,500$41.00$184,500.00View SEC Filing  
3/4/2014Vladimir OstoichVPSell9,800$38.53$377,594.00View SEC Filing  
2/24/2014Kenneth AronCTOSell1,000$38.98$38,980.00View SEC Filing  
2/13/2014Donald Peter WoodCOOSell8,864$38.50$341,264.00View SEC Filing  
6/7/2013Clinton SeversonCEOSell10,000$44.50$445,000.00View SEC Filing  
6/7/2013Martin MulroyInsiderSell14,000$44.80$627,200.00View SEC Filing  
5/22/2013Kenneth AronCTOSell4,200$43.28$181,776.00View SEC Filing  
5/7/2013Achim HenkelDirectorSell5,000$44.07$220,350.00View SEC Filing  
3/1/2013Achim HenkelDirectorSell1,000$42.85$42,850.00View SEC Filing  
2/26/2013Martin MulroyInsiderSell12,000$41.84$502,080.00View SEC Filing  
2/5/2013Kenneth AronCTOSell40,000$44.13$1,765,200.00View SEC Filing  
2/4/2013Martin MulroyInsiderSell12,000$43.97$527,640.00View SEC Filing  
11/23/2012Richard BastianiDirectorSell5,000$36.60$183,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for ABAXIS (NASDAQ:ABAX)
Latest Headlines for ABAXIS (NASDAQ:ABAX)
finance.yahoo.com logoAbaxis To Report Second Quarter Fiscal Year 2018 Financial Results On Tuesday, October 24, 2017
finance.yahoo.com - October 17 at 3:17 PM
americanbankingnews.com logoABAXIS, Inc. (ABAX) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - October 16 at 5:02 AM
americanbankingnews.com logoContrasting Hologic (HOLX) and ABAXIS (ABAX)
www.americanbankingnews.com - October 16 at 12:08 AM
americanbankingnews.com logoABAXIS (ABAX) & Its Competitors Financial Comparison
www.americanbankingnews.com - October 13 at 10:28 PM
finance.yahoo.com logoETFs with exposure to ABAXIS, Inc. : October 10, 2017
finance.yahoo.com - October 10 at 3:19 PM
americanbankingnews.com logo$61.49 Million in Sales Expected for ABAXIS, Inc. (ABAX) This Quarter
www.americanbankingnews.com - October 7 at 9:38 AM
finance.yahoo.com logoABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : October 6, 2017
finance.yahoo.com - October 6 at 3:42 PM
finance.yahoo.com logoABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : October 5, 2017
finance.yahoo.com - October 5 at 12:38 PM
thestreet.com logoAbaxis Reaches Analyst Target Price
www.thestreet.com - October 3 at 8:07 PM
finance.yahoo.com logoETFs with exposure to ABAXIS, Inc. : September 27, 2017
finance.yahoo.com - October 2 at 3:07 PM
americanbankingnews.com logoContrasting ABAXIS (ABAX) and Its Rivals
www.americanbankingnews.com - September 27 at 6:28 PM
americanbankingnews.com logoABAXIS, Inc. (ABAX) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - September 23 at 10:48 PM
finance.yahoo.com logoAbaxis, Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
finance.yahoo.com - September 19 at 3:18 PM
finance.yahoo.com logoNew Strong Sell Stocks for September 11th
finance.yahoo.com - September 11 at 3:44 PM
prnewswire.com logoAbaxis, Inc. to Present at the Morgan Stanley 15th Annual Global Healthcare ...
www.prnewswire.com - September 8 at 8:28 PM
finance.yahoo.com logoAbaxis, Inc. to Present at the Morgan Stanley 15th Annual Global Healthcare Conference and the CL King 15th Annual Best Ideas Conference 2017
finance.yahoo.com - September 8 at 8:28 PM
americanbankingnews.com logoContrasting Alere (ALR) and ABAXIS (ABAX)
www.americanbankingnews.com - September 8 at 6:10 AM
finance.yahoo.com logoETFs with exposure to ABAXIS, Inc. : September 7, 2017
finance.yahoo.com - September 7 at 3:17 PM
finance.yahoo.com logoABAXIS, Inc. :ABAX-US: Earnings Analysis: Q1, 2018 By the Numbers : September 5, 2017
finance.yahoo.com - September 5 at 3:17 PM
finance.yahoo.com logoAbaxis, Inc. to Present at the Robert W. Baird & Co. 2017 Global Healthcare Conference
finance.yahoo.com - August 31 at 3:17 PM
bizjournals.com logoVeterinary Diagnostics Market by Product, Technology, Animal Type And End User - Global Forecast to 2022
www.bizjournals.com - August 30 at 8:16 PM
finance.yahoo.com logoABAXIS, Inc. : ABAX-US: Dividend Analysis : September 01st, 2017 (record date) : By the numbers : August 30, 2017
finance.yahoo.com - August 30 at 3:14 PM
americanbankingnews.com logoABAXIS, Inc. (ABAX) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - August 30 at 12:44 AM
americanbankingnews.com logo Brokerages Expect ABAXIS, Inc. (ABAX) to Announce $0.29 Earnings Per Share
www.americanbankingnews.com - August 29 at 4:08 AM
nasdaq.com logoEx-Dividend Reminder: Abaxis, McKesson and Baxter International
www.nasdaq.com - August 28 at 3:29 PM
americanbankingnews.com logoABAXIS, Inc. (ABAX) Coverage Initiated by Analysts at Bank of America Corporation
www.americanbankingnews.com - August 23 at 9:30 AM
finance.yahoo.com logoWhat Falling Estimates & Price Mean for Abaxis (ABAX)
finance.yahoo.com - August 21 at 3:23 PM
finance.yahoo.com logoNew Strong Sell Stocks for August 21st
finance.yahoo.com - August 21 at 3:23 PM
prnewswire.com logoVeterinary Hematology Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
www.prnewswire.com - August 8 at 8:32 PM
americanbankingnews.com logoABAXIS, Inc. (NASDAQ:ABAX) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - August 5 at 12:38 AM
finance.yahoo.com logoABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : August 4, 2017
finance.yahoo.com - August 4 at 2:06 AM
finance.yahoo.com logoAbaxis, Inc. to Present at the Canaccord Genuity 37th Annual Growth Conference
finance.yahoo.com - August 3 at 3:38 PM
finance.yahoo.com logoABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : July 31, 2017
finance.yahoo.com - August 2 at 3:15 PM
finance.yahoo.com logoETFs with exposure to ABAXIS, Inc. : August 1, 2017
finance.yahoo.com - August 1 at 8:28 PM
finance.yahoo.com logoNew Strong Sell Stocks for August 1st
finance.yahoo.com - August 1 at 3:27 PM
finance.yahoo.com logoEdited Transcript of ABAX earnings conference call or presentation 27-Jul-17 8:15pm GMT
finance.yahoo.com - July 28 at 3:29 PM
finance.yahoo.com logoAbaxis (ABAX) Misses Earnings & Revenue Estimates in Q1
finance.yahoo.com - July 28 at 3:29 PM
seekingalpha.com logoABAXIS (ABAX) Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - July 28 at 1:31 AM
americanbankingnews.com logoABAXIS, Inc. (ABAX) Issues Earnings Results
www.americanbankingnews.com - July 27 at 11:14 PM
finance.yahoo.com logoAbaxis Reports Financial Performance for the First Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend
finance.yahoo.com - July 27 at 8:30 PM
finance.yahoo.com logoAbaxis misses Street 1Q forecasts
finance.yahoo.com - July 27 at 8:30 PM
americanbankingnews.com logoABAXIS, Inc. (NASDAQ:ABAX) Plans Quarterly Dividend of $0.14
www.americanbankingnews.com - July 27 at 5:29 PM
americanbankingnews.com logoHead to Head Survey: Cogentix Medical (CGNT) vs. ABAXIS (ABAX)
www.americanbankingnews.com - July 26 at 8:54 AM
finance.yahoo.com logoABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : July 21, 2017
finance.yahoo.com - July 21 at 4:27 PM
bizjournals.com logoVeterinary Chemistry Analyzer Market by Product Application & Animal - Global Forecast to 2022
www.bizjournals.com - July 21 at 1:27 AM
americanbankingnews.com logoABAXIS, Inc. (NASDAQ:ABAX) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - July 20 at 7:51 AM
finance.yahoo.com logoMedical Product Stocks' Earnings on Jul 20: ABT, ISRG & More
finance.yahoo.com - July 19 at 3:20 PM
prnewswire.com logoAbaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday ...
www.prnewswire.com - July 18 at 3:21 PM
finance.yahoo.com logoAbaxis To Report First Quarter Fiscal Year 2018 Financial Results On Thursday, July 27, 2017
finance.yahoo.com - July 18 at 3:21 PM
americanbankingnews.com logoABAXIS, Inc. (ABAX) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - July 17 at 7:30 AM



ABAXIS (ABAX) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.